 - Histologically- or cytologically- confirmed myeloid malignancy as confirmed by IWG-MRT or WHO diagnostic criteria that is relapsed or refractory to standard treatments. AML, MDS that is very high- or high-risk as defined by the IPSS-R, and Philadelphia chromosome positive malignancies are excluded. 